Literature DB >> 31767074

Serological study reveal different antigenic IBDV strains prevalent in southern China during the years 2000-2017 and also the antigenic differences between the field strains and the commonly used vaccine strains.

Xiumiao He1, Weiwei Wang2, Guo Chen2, Pengtao Jiao2, Zhonghua Ji2, Lin Yang3, Ping Wei4.   

Abstract

The aim of this study was to determine the antigenic relatedness of Infectious Bursal Disease Viruses (IBDVs) in the field in southern China during the period 2000-2017, as well as the antigenic relationship between the field strains and the most commonly used vaccine strains by using a virus neutralization (VN) test in vitro. The antigenic relatedness (R) value and the difference in VN titers were analyzed, and the antigenic index based on the sequences of the hypervariable region of VP2 (vVP2) of the strains was further evaluated. As a result, the R value of representative field strains showed that there were three subtypes present in the field strains examined, with 7 strains belonging to subtype 1, while strains BH11 and JS7 belonged to subtype 2 and subtype 3, respectively. The commonly used vaccine strains B87 and FW2512 belonged to subtype 1. The analysis of the VN titer differences revealed that all the 136 field strains were classified into subtype 1, except BH11 and JS7. All the field strains in subtype 1 have been divided into at least 5 subgroups, suggesting the antigenic diversity among these strains. The antigenic index based on IBDV-VP2 sequences further confirmed the antigenic differences between the three subtype strains and also the antigenic diversity among the subtype 1. The results demonstrated the antigenic diversity of field IBDVs in southern China during the years 2000-2017 and the antigenic differences between the field strains and the commonly used vaccine strains. This would indicate that the commonly used vaccines are only partially effective. These results enhance our understanding of IBDV genetic evolution and should help to develop more effective vaccines for the control of this disease in the future.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antigenicity; Cross virus neutralization (VN) test; Infectious Bursal Disease Virus; Subtype

Mesh:

Substances:

Year:  2019        PMID: 31767074     DOI: 10.1016/j.vetmic.2019.108458

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  The Full Region of N-Terminal in Polymerase of IBDV Plays an Important Role in Viral Replication and Pathogenicity: Either Partial Region or Single Amino Acid V4I Substitution Does Not Completely Lead to the Virus Attenuation to Three-Yellow Chickens.

Authors:  Weiwei Wang; Yu Huang; Zhonghua Ji; Guo Chen; Yan Zhang; Yuanzheng Qiao; Mengya Shi; Min Li; Teng Huang; Tianchao Wei; Meilan Mo; Xiumiao He; Ping Wei
Journal:  Viruses       Date:  2021-01-14       Impact factor: 5.048

2.  Development of a Viral-Like Particle Candidate Vaccine Against Novel Variant Infectious Bursal Disease Virus.

Authors:  Yulong Wang; Nan Jiang; Linjin Fan; Li Gao; Kai Li; Yulong Gao; Xinxin Niu; Wenying Zhang; Hongyu Cui; Aijing Liu; Qing Pan; Changjun Liu; Yanping Zhang; Xiaomei Wang; Xiaole Qi
Journal:  Vaccines (Basel)       Date:  2021-02-10

3.  A Single Vaccination of IBDV Subviral Particles Generated by Kluyveromyces marxianus Efficiently Protects Chickens against Novel Variant and Classical IBDV Strains.

Authors:  Deqiang Yang; Lixia Zhang; Jinkun Duan; Qiang Huang; Yao Yu; Jungang Zhou; Hong Lu
Journal:  Vaccines (Basel)       Date:  2021-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.